Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Hepatitis C Virus Chronic Infection”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT02636608
What this trial is testing

Real World Evidence of the Effectiveness of Paritaprevir/r - Ombitasvir, ± Dasabuvir, ± Ribavirin in Patients With Chronic Hepatitis C - An Observational Study in Hungary

Who this might be right for
Chronic Hepatitis C
AbbVie 244
Early research (Phase 1)Ended earlyNCT00954993
What this trial is testing

Pharmacokinetics of Vaniprevir (MK-7009) and Hepatitis C Virus RNA Levels After Vaniprevir Treatment (MK-7009-029)

Who this might be right for
Chronic Hepatitis C Infection
Merck Sharp & Dohme LLC 3
Testing effectiveness (Phase 2)Study completedNCT00556504
What this trial is testing

The Effects of Adding TCM-700C on the Standard Combination Treatment for Patients With Genotype 1 Hepatitis C Infection

Who this might be right for
Chronic Hepatitis C
TCM Biotech International Corp. 84
Large-scale testing (Phase 3)Study completedNCT01330316
What this trial is testing

A Rollover Study of BI 201335 in Combination With Pegylated Interferon-alpha and Ribavirin in Treatment-experienced Genotype 1 Hepatitis C Infected Patients

Who this might be right for
Hepatitis C
Boehringer Ingelheim 119
Testing effectiveness (Phase 2)UnknownNCT00408304
What this trial is testing

Prevention of Depression With Omega-3 Fatty Acids in Chronic Carriers of Hepatitis C Treated With Interferon Alpha.

Who this might be right for
Chronic Hepatitis C
Bnai Zion Medical Center 60
Post-approval studies (Phase 4)Study completedNCT00495131
What this trial is testing

Randomized Trial of 24 or 48 Weeks of Peginterferon Alfa-2a Plus Ribavirin for HCV Genotype 1-infected Patients

Who this might be right for
Hepatitis C, Chronic
National Taiwan University Hospital 308
Testing effectiveness (Phase 2)UnknownNCT00225537
What this trial is testing

4-Methylumbelliferone as a Treatment for Chronic HBV/HCV

Who this might be right for
Chronic Hepatitis CChronic Hepatitis B
MTmedical Institute of Health 160
Large-scale testing (Phase 3)Ended earlyNCT00296972
What this trial is testing

Tolerability of Peginterferon Plus Ribavirin for Chronic Hepatitis C and HIV for Patients Receiving Antiretroviral Medication vs Not Receiving Antiretroviral Medication

Who this might be right for
Chronic Hepatitis CHIV Infections
University Health Network, Toronto 100
Post-approval studies (Phase 4)UnknownNCT01025765
What this trial is testing

The Effects of Oral Hypoglycemic Agents on Chronic Hepatitis C Patients Receiving Peg-Intron Plus Ribavirin

Who this might be right for
Chronic Hepatitis C
National Taiwan University Hospital 80
Large-scale testing (Phase 3)WithdrawnNCT01296971
What this trial is testing

The Safety of Individualized Combination Therapy With Copegus (Ribavirin) and Pegasys (Peginterferon Alfa-2a) in Patients With Chronic Hepatitis C (MASTER)

Who this might be right for
Hepatitis C, Chronic
Hoffmann-La Roche
Testing effectiveness (Phase 2)Study completedNCT00926120
What this trial is testing

The Effects of Mogroside Sweetener on Viral Load in TreatmenT Naive Genotype 1 (GT 1) Subjects CHC

Who this might be right for
Hepatitis C
Brooke Army Medical Center 10
Not applicableWithdrawnNCT01062659
What this trial is testing

Cellular Immune Responses in the Liver in Chronic Hepatitis C (CHC) Patients

Who this might be right for
Hepatitis C, ChronicLiver DiseasesVirus Diseases
University of Ulm
Large-scale testing (Phase 3)Study completedNCT00483938
What this trial is testing

The Individualized Management With Pegylated-interferon Alfa-2a (Pegasys) and Ribavirin (Copegus) Offering Viral Eradication: A Study of Pegylated-interferon Alfa-2a Plus Ribavirin in Participants With Chronic Hepatitis C (CHC) Non-genotype 2/3 (IMPROVE)

Who this might be right for
Hepatitis C, Chronic
Hoffmann-La Roche 236
Not applicableStudy completedNCT02400216
What this trial is testing

Deciphering the Mechanisms Involved in Microbial Translocation Across the Spectrum of HCV Associated Liver Fibrosis

Who this might be right for
Cirrhosis
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) 30
Large-scale testing (Phase 3)Study completedNCT02555943
What this trial is testing

DAAs Treatment for Chronic HCV/HBV Co-infection Patients(DASCO)

Who this might be right for
Chronic Hepatitis C InfectionHBV CoinfectionHepatitis B Reactivation
Humanity and Health Research Centre 23
Testing effectiveness (Phase 2)Study completedNCT01852604
What this trial is testing

Samatasvir (IDX719) in Combinations With Simeprevir and/or TMC647055/Ritonavir With or Without Ribavirin for 12 Weeks in Participants With Chronic Hepatitis C Infection (MK-1894-005)

Who this might be right for
Chronic Hepatitis C Virus
Merck Sharp & Dohme LLC 143
Testing effectiveness (Phase 2)Study completedNCT01648140
What this trial is testing

Dose Ranging of GSK2336805 in Combination Therapy

Who this might be right for
Hepatitis C, Chronic
GlaxoSmithKline 286
Large-scale testing (Phase 3)Study completedNCT02220998
What this trial is testing

Comparison of Sofosbuvir/Velpatasvir Fixed Dose Combination for 12 Weeks With Sofosbuvir and Ribavirin for 12 Weeks in Adults With Chronic Genotype 2 HCV Infection

Who this might be right for
Hepatitis C Virus Infection
Gilead Sciences 269
Large-scale testing (Phase 3)Study completedNCT04155515
What this trial is testing

A Phase III Study to Evaluate Efficacy and Safety of TG-2349 in Combination With DAG181 and RBV for HCV Type I Patients

Who this might be right for
Chronic Hepatics C Virus (HCV) Genotype 1Non-CirrhoticCirrhosis+1 more
Dongguan HEC TaiGen Biopharmaceuticals Co., Ltd. 370
Large-scale testing (Phase 3)UnknownNCT02371408
What this trial is testing

The Efficacy and Safety of PPI-668 (NS5A Inhibitor) Plus Sofosbuvir, With or Without Ribavirin, in Patients With Chronic Hepatitis C Genotype-4

Who this might be right for
Chronic Hepatitis C
Pharco Pharmaceuticals 300
Next Page